All Journals > Clinical Infectious Diseases > 15 January 2003 > Bacterial Resistance

Article Tools

Search for Related Articles

Announcements

CID LISTED AMONG
“MOST INFLUENTIAL”

Clinical Infectious Diseases has been named as one of the "100 Most Influential Journals in Biology and Medicine" of the past 100 years by the Special Libraries Association. The list was compiled by the 680-plus members of SLA’s Biomedical and Life Sciences Division.

See the full list here.

Source: The DBIO 100, the 100 Most Influential Journals in Biology & Medicine over the last 100 Years

In the News

Featured in MSNBC
"Germs and flu are up; infection control is down" June 9, 2009
Trends in the Incidence of Methicillin‐Resistant Staphylococcus aureus Infection in Children’s Hospitals in the United States
Jeffrey S. Gerber, Susan E. Coffin, Sarah A. Smathers, and Theoklis E. Zaoutis
Just this week, researchers reported that the incidence of MRSA infections among children admitted to pediatric hospitals in the United States more than tripled between 2002 and 2007. Researchers at the Children’s Hospital of Philadelphia and the University of Pennsylvania found cases of MRSA jumped from 6.7 per 1,000 admissions in 2002 to 21.1 cases per 1,000 admissions in 2007, according to a study released online Monday in the journal Clinical Infectious Diseases.

Featured in Toronto Star
"Pigs, viruses and politics" May 2, 2009
Are Swine Workers in the United States at Increased Risk of Infection with Zoonotic Influenza Virus?
Kendall P. Myers, Christopher W. Olsen, Sharon F. Setterquist, Ana W. Capuano, Kelley J. Donham, Eileen L. Thacker, James A. Merchant, and Gregory C. Gray
Another study, this one published in the U.S. journal Clinical Infectious Diseases in 2006, found that workers in meat-processing plants have a greater likelihood of being infected by some version of the H1N1 flu virus than the general population (the odds of pig farmers getting the disease are significantly greater again).

Featured in Philadelphia Inquirer
"A shot in the arm for vaccines" April 19, 2009
Vaccines: Pneumococcal Vaccination of Elderly Adults: New Paradigms for Protection
Lisa A. Jackson and Edward N. Janoff
Every year, an estimated 915,000 people 65 and older get pneumonia, and 40 percent of them end up in hospitals, according to a 2004 paper in the journal Clinical Infectious Diseases. Pneumonia often kills older people, said Richard Stefanacci, a geriatrician at the University of the Sciences in Philadelphia.

15 January 2003 Supplement

Volume 36, Number S1
Clinical Infectious Diseases 2003;36:S11–S23
© 2003 by the Infectious Diseases Society of America. All rights reserved.
1058-4838/2003/3602S1-0004$15.00
DOI: 10.1086/344654
SUPPLEMENT ARTICLE

Bacterial Resistance: Origins, Epidemiology, and Impact

David M. Livermore

Antibiotic Resistance Monitoring and Reference Laboratory, Central Public Health Laboratory, London, United Kingdom

The basic mechanisms of antibacterial resistance are well known, but critical new aspects continue to be discovered. Recently discovered factors with major implications for the emergence, dissemination, and maintenance of resistance include multidrug efflux, hypermutability, integrons, and plasmid addiction. Some resistances are widespread and others local, with prevalence rates often worst in newly prosperous countries and in those specialist units where antibacterial use is heaviest. Multidrug‐resistant epidemic strains are critical to the total accumulation of resistance (e.g., among Streptococcus pneumoniae, methicillin‐resistant Staphylococcus aureus, Klebsiella pneumoniae), but it remains unclear why some bacterial lineages achieve epidemic spread whereas others that are equally resistant do not. The correlation between in vitro resistance and treatment failure is imperfect, but resistance undoubtedly increases mortality, morbidity, and costs in many settings. Recent concern has led to a plethora of governmental and agency reports advocating less antibacterial use, better antibacterial use, better infection control, and the development of new antibacterials. The evidence that better prescribing can reduce resistance rates is mixed, and although changes to hospital regimens may reduce one resistance problem, other opportunistic bacteria may fill the vacant niche. Overall, the best that can reasonably be anticipated is an improved balance between the accumulation of resistance and new antibacterial development.

Reprints or correspondence: Dr. David M. Livermore, Antibiotic Resistance Monitoring and Reference Laboratory, Central Public Health Laboratory, 61 Colindale Ave., London NW9 5HT, United Kingdom ().

Cited by

Reuven Friedmann, MD; David Raveh, MD; Esther Zartzer, MD; Bernard Rudensky, PhD; Ellen Broide, BSc; Denise Attias, BSc; Amos M. Yinnon, MD. (2009) Prospective Evaluation of Colonization with Extended‐Spectrum β‐Lactamase (ESBL)–Producing Enterobacteriaceae Among Patients at Hospital Admission and of Subsequent Colonization with ESBL‐Producing Enterobacteriaceae Among Patients During Hospitalization •. Infection Control and Hospital Epidemiology 30:6, 534-542
Online publication date: 1-Jun-2009.
Abstract-Full Text-PDF Version (216 kB)
Nitin Bhanot, MD, MPH; Edward K. Chapnick, MD; Shobha Sharma, DO; Ceres Tiu, MD; Monica Ghitan, MD; Andrew G. Sahud, MD. (2009) Colonization or Infection of the Urinary Tract: Do We Pay Attention? •. Infection Control and Hospital Epidemiology 30:5, 501-502
Online publication date: 1-May-2009.
Citation-Full Text-PDF Version (216 kB)
R. Naesens, J. P. Ursi, J. Schaeren, A. Jeurissen. (2009) In vitro activity of tigecycline against multidrug-resistant Enterobacteriaceae isolates from a Belgian hospital. European Journal of Clinical Microbiology & Infectious Diseases 28:4, 381-384
Online publication date: 1-May-2009.
CrossRef
Begoña Heras, Stephen R. Shouldice, Makrina Totsika, Martin J. Scanlon, Mark A. Schembri, Jennifer L. Martin. (2009) DSB proteins and bacterial pathogenicity. Nature Reviews Microbiology 7:3, 215-225
Online publication date: 1-Apr-2009.
CrossRef
L. R. Peterson. (2009) Currently available antimicrobial agents and their potential for use as monotherapy. Clinical Microbiology and Infection 14, 30-45
Online publication date: 1-Jan-2009.
CrossRef
Oscar Cirioni, Roberto Ghiselli, Linda Tomasinsig, Fiorenza Orlando, Carmela Silvestri, Barbara Skerlavaj, Alessandra Riva, Marco Rocchi, Vittorio Saba, Margherita Zanetti, Giorgio Scalise, Andrea Giacometti. (2008) EFFICACY OF LL-37 AND GRANULOCYTE COLONY-STIMULATING FACTOR IN A NEUTROPENIC MURINE SEPSIS DUE TO PSEUDOMONAS AERUGINOSA. Shock 30:4, 443-448
Online publication date: 1-Nov-2008.
CrossRef
Oguz Resat Sipahi. (2008) Economics of antibiotic resistance. Expert Review of Anti-infective Therapy 6:4, 523-539
Online publication date: 1-Sep-2008.
CrossRef
David J. Stokes, Alison F. Kelly, Simon W.J. Gould, Claire A. Cassar, Mark D. Fielder. (2008) The withdrawal of antimicrobial treatment as a mechanism for defeating resistant microorganisms. FEMS Immunology & Medical Microbiology 0:0, 080612073358959-???
Online publication date: 12-Jul-2008.
CrossRef
A. M. Sostarich, D. Zolldann, H. Haefner, R. Luetticken, R. Schulze-Roebecke, S. W. Lemmen. (2008) Impact of Multiresistance of Gram-negative Bacteria in Bloodstream Infection on Mortality Rates and Length of Stay. Infection 36:1, 31-35
Online publication date: 1-Mar-2008.
CrossRef
E. Raum, S. Lietzau, H. von Baum, R. Marre, H. Brenner. (2008) Changes in Escherichia coli resistance patterns during and after antibiotic therapy: a longitudinal study among outpatients in Germany. Clinical Microbiology and Infection 14:1, 41-48
Online publication date: 1-Feb-2008.
CrossRef
Sudeshna Ghosh, Timothy M LaPara. (2007) The effects of subtherapeutic antibiotic use in farm animals on the proliferation and persistence of antibiotic resistance among soil bacteria. The ISME Journal 1:3, 191-203
Online publication date: 1-Aug-2007.
CrossRef
Javier Álvarez, Miguel Vicente. (2007) Using genomics to identify new targets and counteract resistance to antibiotics. Expert Opinion on Therapeutic Patents 17:6, 667-674
Online publication date: 1-Jul-2007.
CrossRef
Claude G. Lerner, Philip J. Hajduk, Rolf Wagner, Frank L. Wagenaar, Charlotte Woodall, Yu-Gui Gu, Xenia B. Searle, Alan S. Florjancic, Tianyuan Zhang, Richard F. Clark, Curt S. Cooper, Jamey C. Mack, Liping Yu, Mengli Cai, Steven F. Betz, Linda E. Chovan, J. Owen McCall, Candace L. Black-Schaefer, Stephan J. Kakavas, Mark E. Schurdak, Kenneth M. Comess, Karl A. Walter, Rohinton Edalji, Sarah A. Dorwin, Richard A. Smith, Eric J. Hebert, John E. Harlan, Randy E. Metzger, Philip J. Merta, John L. Baranowski, Michael L. Coen, Susan J. Thornewell, Annapur G. Shivakumar, Anne Y. Saiki, Niru Soni, Mai Bui, Darlene J. Balli, William J. Sanders, Angela M. Nilius, Thomas F. Holzman, Stephen W. Fesik, Bruce A. Beutel. (2007) From Bacterial Genomes to Novel Antibacterial Agents: Discovery, Characterization, and Antibacterial Activity of Compounds that Bind to HI0065 (YjeE) from Haemophilus influenzae. Chemical Biology & Drug Design 69:6, 395-404
Online publication date: 1-Jul-2007.
CrossRef
A L Oliveira, M de Souza, V M H Carvalho-Dias, M A Ruiz, L Silla, P Yurie Tanaka, B P Simões, P Trabasso, A Seber, C J Lotfi, M A Zanichelli, V R Araujo, C Godoy, A Maiolino, P Urakawa, C A Cunha, C A de Souza, R Pasquini, M Nucci. (2007) Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients. Bone Marrow Transplantation 39:12, 775-781
Online publication date: 1-Jul-2007.
CrossRef
Emilia Cercenado. (2007) Tigecycline: a new antimicrobial agent against multiresistant bacteria. Therapy 4:3, 255-270
Online publication date: 1-Jun-2007.
CrossRef
P. Hawkey, R. Finch. (2007) Tigecycline: in-vitro performance as a predictor of clinical efficacy. Clinical Microbiology and Infection 13:4, 354-362
Online publication date: 1-May-2007.
CrossRef
Moise L Levy, Jeffrey M Weinberg. (2007) Current issues in uncomplicated skin and skin structure infections. Expert Review of Dermatology 2:2, 153-165
Online publication date: 1-May-2007.
CrossRef
D.B. Blossom, S.M. Cordeiro, S. Bajaksouzian, M.L. Joloba, C. Kityo, C.C. Whalen, R.A. Salata, M.R. Jacobs. (2007) Characterization of Penicillin Intermediate Serotypes of Streptococcus pneumoniae Carried by Human Immunodeficiency Virus-Infected Adults and Healthy Children in Uganda. Microbial Drug Resistance 13:1, 21-28
Online publication date: 1-Apr-2007.
CrossRef
Franz von Nussbaum, Michael Brands, Berthold Hinzen, Stefan Weigand, Dieter Häbich. (2006) Antibakterielle Naturstoffe in der medizinischen Chemie – Exodus oder Renaissance?. Angewandte Chemie 118:31, 5194-5254
Online publication date: 4-Sep-2006.
CrossRef
Franz von Nussbaum, Michael Brands, Berthold Hinzen, Stefan Weigand, Dieter Häbich. (2006) Antibacterial Natural Products in Medicinal Chemistry—Exodus or Revival?. Angewandte Chemie International Edition 45:31, 5072-5129
Online publication date: 4-Sep-2006.
CrossRef
Marin H. Kollef. (2006) Is Antibiotic Cycling the Answer to Preventing the Emergence of Bacterial Resistance in the Intensive Care Unit?. Clinical Infectious Diseases 43:s2, S82-S88
Online publication date: 1-Sep-2006.
Abstract-Full Text-PDF Version (111 kB)
Jodi A. Lindsay, Matthew T. G. Holden. (2006) Understanding the rise of the superbug: investigation of the evolution and genomic variation of Staphylococcus aureus. Functional & Integrative Genomics 6:3, 186-201
Online publication date: 1-Aug-2006.
CrossRef
Marin H. Kollef. (2006) The Intensive Care Unit as a Research Laboratory: Developing Strategies to Prevent Antimicrobial Resistance. Surgical Infections 7:2, 85-99
Online publication date: 1-May-2006.
CrossRef
J. L. Nouwen. (2006) Editorial Commentary: Controlling Antibiotic Use and Resistance. Clinical Infectious Diseases 42:6, 776-777
Online publication date: 15-Mar-2006.
Citation-Full Text-PDF Version (45 kB)
T. R. Fritsche, M. G. Stilwell, R. N. Jones. (2006) Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003). Clinical Microbiology and Infection 11:12, 974-984
Online publication date: 1-Jan-2006.
CrossRef
L. R. Peterson. (2005) Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance. Clinical Microbiology and Infection 11:s5, 4-16
Online publication date: 1-Nov-2005.
CrossRef
Mark H Wilcox. (2005) Update on linezolid: the first oxazolidinone antibiotic. Expert Opinion on Pharmacotherapy 6:13, 2315-2326
Online publication date: 1-Nov-2005.
CrossRef
Robert P. Rapp. (2005) Introduction. Pharmacotherapy 25:10, 41S-43S
Online publication date: 1-Oct-2005.
CrossRef
Gary E. Stein. (2005) Antimicrobial Resistance in the Hospital Setting: Impact, Trends, and Infection Control Measures. Pharmacotherapy 25:10, 44S-54S
Online publication date: 1-Oct-2005.
CrossRef
Gary E. Stein. (2005) Safety of Newer Parenteral Antibiotics. Clinical Infectious Diseases 41:s5, S293-S302
Online publication date: 1-Sep-2005.
Abstract-Full Text-PDF Version (122 kB)
Marin H. Kollef, Scott T. Micek. (2005) Strategies to prevent antimicrobial resistance in the intensive care unit. Critical Care Medicine 33:8, 1845-1853
Online publication date: 1-Sep-2005.
CrossRef
Terry A. Krulwich, Oded Lewinson, Etana Padan, Eitan Bibi. (2005) Opinion: Do physiological roles foster persistence of drug/multidrug-efflux transporters? A case study. Nature Reviews Microbiology 3:7, 566-572
Online publication date: 1-Aug-2005.
CrossRef
John F Barrett. (2005) MRSA – what is it, and how do we deal with the problem?. Expert Opinion on Therapeutic Targets 9:2, 253-265
Online publication date: 1-May-2005.
CrossRef
Maciej F. Boni, Marcus W. Feldman. (2005) EVOLUTION O ANTIBIOTIC RESISTANCE BY HUMAN AND BACTERIAL NECHE CONSTRUCTION. Evolution 59:3, 477-491
Online publication date: 1-Apr-2005.
CrossRef
Maciej F. Boni, Marcus W. Feldman. (2005) EVOLUTION OF ANTIBIOTIC RESISTANCE BY HUMAN AND BACTERIAL NICHE CONSTRUCTION. Evolution 59:3, 477
Online publication date: 1-Feb-2005.
CrossRef
Wafaa Jamal, V.O. Rotimi, Fatima Khodakhast, Rolla Saleem, Aleyamma Pazhoor, Ghyada Al Hashim. (2005) Prevalence of Extended-Spectrum Beta-Lactamases in Enterobacteriaceae, <i>Pseudomonas </i>and <i>Stenotrophomonas</i> as Determined by the VITEK 2 and E Test Systems in a Kuwait Teaching Hospital. Medical Principles and Practice 14:5, 325-331
Online publication date: 1-Feb-2005.
CrossRef
Lou Ann Bruno‐Murtha, DO; John Brusch, MD; David Bor, MD; Wenjun Li, PhD; Deborah Zucker, MD, PhD. (2005) A Pilot Study of Antibiotic Cycling in the Community Hospital Setting •. Infection Control and Hospital Epidemiology 26:1, 81-87
Online publication date: 1-Jan-2005.
Abstract-PDF Version (100 kB)
D.M. Livermore. (2004) The need for new antibiotics. Clinical Microbiology and Infection 10:s4, 1-9
Online publication date: 1-Dec-2004.
CrossRef
Jean Carlet, Adel Ben Ali, Annie Chalfine. (2004) Epidemiology and control of antibiotic resistance in the intensive care unit. Current Opinion in Infectious Diseases 17:4, 309-316
Online publication date: 1-Sep-2004.
CrossRef
Thomas D Gootz. (2004) Global dissemination of 2-lactamases mediating resistance to cephalosporins and carbapenems. Expert Review of Anti-infective Therapy 2:2, 317-327
Online publication date: 1-May-2004.
CrossRef
John E. McGowan, Jr.. (2004) Editorial Commentary: Minimizing Antimicrobial Resistance: The Key Role of the Infectious Diseases Physician. Clinical Infectious Diseases 38:7, 939-942
Online publication date: 1-Apr-2004.
Citation-Full Text-PDF Version (71 kB)
K. Poole. (2004) Efflux-mediated multiresistance in Gram-negative bacteria. Clinical Microbiology and Infection 10:1, 12-26
Online publication date: 1-Feb-2004.
CrossRef
David Livermore. (2004) Opinion : Can better prescribing turn the tide of resistance?. Nature Reviews Microbiology 2:1, 73-78
Online publication date: 1-Feb-2004.
CrossRef
Nina M. Clark, Ellie Hershberger, Marcus J. Zervosc, Joseph P. Lynch. (2003) Antimicrobial resistance among gram-positive organisms in the intensive care unit. Current Opinion in Critical Care 9:5, 403-412
Online publication date: 1-Nov-2003.
CrossRef
Linda L. Tikofsky, John W. Barlow, Carlos Santisteban, Ynte H. Schukken. (2003) A Comparison of Antimicrobial Susceptibility Patterns for Staphylococcus aureus in Organic and Conventional Dairy Herds. Microbial Drug Resistance 9:1, Supplement 1, 39-45
Online publication date: 1-Nov-2003.
CrossRef
Martin J. Wood and Robert C. Moellering, Jr.. (2003) Introduction: Microbial Resistance: Bacteria and More. Clinical Infectious Diseases 36:s1, S2-S3
Online publication date: 15-Jan-2003.
Citation-Full Text-PDF Version (44 kB)
Back to Top
Close Popup